Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways
- DOI
- 10.1097/mou.0b013e3283097889
- Published
- 2008-09
- Container
- Current Opinion in Urology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/mou.0b013e3283097889,
title = {Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways},
author = {Hervé Wallerand and Robert R Reiter and Alain Ravaud},
year = {2008},
journal = {Current Opinion in Urology},
doi = {10.1097/mou.0b013e3283097889},
url = {https://doi.org/10.1097/mou.0b013e3283097889}
}RIS
TY - JOUR TI - Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways AU - Hervé Wallerand AU - Robert R Reiter AU - Alain Ravaud PY - 2008 JO - Current Opinion in Urology DO - 10.1097/mou.0b013e3283097889 UR - https://doi.org/10.1097/mou.0b013e3283097889 ER -
APA
Wallerand, H., Reiter, R. R., & Ravaud, A. (2008). Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways. Current Opinion in Urology. https://doi.org/10.1097/mou.0b013e3283097889
Source records
- crossref · retrieved 2026-11-10T00:54:57.919Z